Drug Type Biosimilar, Enzyme |
Synonyms GNR-105, GNR105 |
Target |
Action- |
Mechanism GALNS replacements(galactosamine (N-acetyl)-6-sulfatase replacements) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Mucopolysaccharidosis IV | Preclinical | Russia | 01 Mar 2026 |






